A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Clinical trial NCT06946641 · RECRUITING

Trial details

NCT number: NCT06946641
Sponsor: Shanghai Qilu Pharmaceutical Research and Development Center LTD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis Hidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)

Start date: 2025-03-31
Primary completion: 2025-12-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.